|
|
???tair.name??? >
???browser.page.title.title???
|
Showing items 771411-771435 of 2348617 (93945 Page(s) Totally)
<< < 30852 30853 30854 30855 30856 30857 30858 30859 30860 30861 > >>
View [10|25|50] records per page
| 中國文化大學 |
2013-02 |
Sorafenib induces autophagy and suppresses activation of human macrophage
|
Lin, JC (Lin, Jiunn-Chang); Liu, CL (Liu, Chien-Liang); Lee, JJ (Lee, Jie-Jen); Liu, TP (Liu, Tsan-Pai); Ko, WC (Ko, Wen-Chin); Huang, YC (Huang, Yu-Chuen); Wu, CH (Wu, Chih-Hsiung); Chen, YJ (Chen, Yu-Jen) |
| 中國文化大學 |
2013-05 |
Sorafenib induces autophagy and suppresses activation of human macrophage (vol 15, pg 333, 2013)
|
Lin, JC (Lin, Jiunn-Chang); Liu, CL (Liu, Chien-Liang); Lee, JJ (Lee, Jie-Jen); Liu, TP (Liu, Tsan-Pai); Ko, WC (Ko, Wen-Chin); Huang, YC (Huang, Yu-Chuen); Wu, CH (Wu, Chih-Hsiung); Chen, YJ (Chen, Yu-Jen) |
| 中國文化大學 |
2013-03-27 |
Sorafenib Induces Autophagy in Human Myeloid Dendritic Cells and Prolongs Survival of Skin Allografts
|
Lin, JC (Lin, Jiunn-Chang); Huang, WP (Huang, Wei-Pang); Liu, CL (Liu, Chien-Liang); Lee, JJ (Lee, Jie-Jen); Liu, TP (Liu, Tsang-Pai); Ko, WC (Ko, Wen-Chin); Huang, YC (Huang, Yu-Chuen); Hsu, ML (Hsu, Ming-Ling); Wu, CH (Wu, Chih-Hsiung); Chen, YJ (Chen, Yu-Jen) |
| 臺北醫學大學 |
2013 |
Sorafenib Induces Autophagy in Human Myeloid Dendritic Cells and Prolongs Survival of Skin Allografts
|
Lin;J, C.;Huang, W. P.;Liu, C. L.;Lee, J. J.;Wu, C. H.;Chen, Y. J. |
| 臺北醫學大學 |
2013 |
Sorafenib Induces Autophagy in Human Myeloid Dendritic Cells and Prolongs Survival of Skin Allografts
|
Lin;J.C.;W.P.Huang;C.L.Liu;J.J.Lee;C.H.Wu;Y.J.Chen |
| 臺大學術典藏 |
2018-09-10T09:44:21Z |
Sorafenib induces autophagy in human myeloid dendritic cells and prolongs survival of skin allografts
|
WEI-PANG HUANG;Chen, Y.-J.;Wu, C.-H.;Hsu, M.-L.;Huang, Y.-C.;Ko, W.-C.;Liu, T.-P.;Lee, J.-J.;Liu, C.-L.;Huang, W.-P.;Lin, J.-C.; Lin, J.-C.; Huang, W.-P.; Liu, C.-L.; Lee, J.-J.; Liu, T.-P.; Ko, W.-C.; Huang, Y.-C.; Hsu, M.-L.; Wu, C.-H.; Chen, Y.-J.; WEI-PANG HUANG |
| 國立臺灣大學 |
2008 |
Sorafenib Is Effective in Patients from the Asia-Pacific Region with Hepatocellular Carcinoma (Hcc) Subgroup Analysis of Effect of Macroscopic Vascular Invasion, Extrahepatic Spread, and Ecog Performance Status on Outcome
|
曹朝榮; 鄭安理; TSAO, CHAO-JUNG; CHENG, ANN-LII |
| 國立臺灣大學 |
2008 |
Sorafenib Overcomes Bortezomib Resistance of Hepatocellular Carcinoma Cells by down-Regulating Phospho-Akt and Bcl-2
|
陳昆鋒; 許駿; 徐志宏; 葉培彥; 李水盛; 陳培哲; 鄭安理; CHEN, KUEN-FENG; HSU, CHIUN; HSU, CHIH-HUNG; YEH, PEI-YEN; LEE, SHOEI-SHENG; CHEN, PEI-JER; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Sorafenib Overcomes Trail Resistance of Hepatocellular Carcinoma Cells through the Inhibition of Signal Transducers and Activators of Transcription 3
|
陳昆鋒; 戴瑋恬; 陳培哲; 鄭安理; CHEN, KUEN-FENG; TAI, WEI-TIEN; CHEN, PEI-JER; CHENG, ANN-LII |
| 國立臺灣大學 |
2010 |
Sorafenib Overcomes Trail Resistance of Hepatocellular Carcinoma Cells through the Inhibition of Stat3
|
陳昆鋒; 黃祥博; 林育靖; 蕭崇瑋; 陳培哲; 鄭安理; CHEN, KUEN-FENG; HUANG, HSIANG-PO; LIN, YU-CHIN; SHIAU, CHUNG-WAI; CHEN, PEI-JER; CHENG, ANN-LII |
| 臺大學術典藏 |
2018-09-10T08:04:03Z |
Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3
|
HSIANG-PO HUANG; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2021-06-03T06:50:19Z |
Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3
|
Chen K.-F.; Tai W.-T.; Liu T.-H.; HSIANG-PO HUANG; Lin Y.-C.; Shiau C.-W.; Li P.-K.; Chen P.-J.; Cheng A.-L. |
| 臺大學術典藏 |
2021-07-03T03:34:40Z |
Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3
|
Chen K.-F.; Tai W.-T.; Liu T.-H.; Huang H.-P.; Lin Y.-C.; Shiau C.-W.; Li P.-K.; PEI-JER CHEN; Cheng A.-L. |
| 臺大學術典藏 |
2021-09-01T01:54:12Z |
Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3
|
Chen K.-F.; Tai W.-T.; Liu T.-H.; Huang H.-P.; Lin Y.-C.; Shiau C.-W.; Li P.-K.; Chen P.-J.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-03-19T01:54:21Z |
Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3
|
Chen K.-F.; Tai W.-T.; TSUNG-HAO LIU; Huang H.-P.; Lin Y.-C.; Shiau C.-W.; Li P.-K.; Chen P.-J.; Cheng A.-L. |
| 義守大學 |
2016-11 |
Sorafenib pretreatment enhances radiotherapy through targeting MEK/ERK/NF-κB pathway in human hepatocellular carcinoma-bearing mouse model
|
John Chun-Hao Chen;Hui-Yen Chuang;Fei-Ting Hsu;Yi-Chen Chen;Yi-Chun Chien;Jeng-Jong Hwang |
| 臺北醫學大學 |
2014 |
Sorafenib Prolongs Skin Allograft Survival Through Upregulation of Treg and Autophagy-Related Mechanism In Vivo
|
Lin, Jiunn-Chang;Liu, Chien-Liang;Lee, Jie-Jen;Liu, Tsang-Pai;Ko, Wen-Ching;Wu, Chih-Hsiung;Chen, Yu-Jen |
| 國立臺灣大學 |
2014 |
Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity
|
Chen, Mei-Ling; Yan, Bo-Shiun; Lu, Wan-Chih; Chen, Mei-Huei; Yu, Sung-Liang; Yang, Pan-Chyr Cheng, Ann-Lii; 俞松良; 楊泮池; 陳美齡; 鄭安理; 顏伯勳 |
| 臺大學術典藏 |
2018-09-10T14:50:19Z |
Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity
|
Chen, M.-L. and Yan, B.-S. and Lu, W.-C. and Chen, M.-H. and Yu, S.-L. and Yang, P.-C. and Cheng, A.-L.; Chen, Mei-Ling;Yan, Bo-Shiun;Lu, Wan-Chih;Chen, Mei-Huei;Yu, Sung-Liang;Yang, Pan-Chyr
Cheng, Ann-Lii; 俞松良;楊泮池;陳美齡;鄭安理;顏伯勳; 俞松良;楊泮池;陳美齡;鄭安理;顏伯勳; Hsu, F.M.; SUNG-LIANG YU; Chen, Mei-Ling; Chen, Mei-Ling; Yan, Bo-Shiun; BO-SHIUN YAN; Hsu, F.M.; ANN-LII CHENG; Lu, Wan-Chih; Chen, Mei-Huei; Chen, Mei-Huei; Yu, Sung-Liang; Yang, Pan-Chyr
Cheng, Ann-Lii; 楊泮池 |
| 臺大學術典藏 |
2020-01-21T01:20:42Z |
Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity
|
Cheng A.-L.; Yang P.-C.; Yu S.-L.; Chen M.-H.; Lu W.-C.; BO-SHIUN YAN; Chen M.-L. |
| 臺大學術典藏 |
2020-12-02T02:33:42Z |
Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity
|
Chen M.-L.;Yan B.-S.;Lu W.-C.;Chen M.-H.;Yu S.-L.;PAN-CHYR YANG;Cheng A.-L.; Chen M.-L.; Yan B.-S.; Lu W.-C.; Chen M.-H.; Yu S.-L.; PAN-CHYR YANG; Cheng A.-L. |
| 臺大學術典藏 |
2021-08-31T06:42:24Z |
Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity
|
Chen M.-L.; Yan B.-S.; Lu W.-C.; Chen M.-H.; Yu S.-L.; Yang P.-C.; ANN-LII CHENG |
| 國立成功大學 |
2022-11 |
Sorafenib suppresses radioresistance and synergizes radiotherapy-mediated CD8(+) T cell activation to eradicate hepatocellular carcinoma
|
Cheng;-Chia, Chun;Ho;Ai-Sheng;Peng;Cheng-Liang;Chang;Jungshan;Sie;Zong-Lin;Wang;Chih-Liang;Chen;Yi-Li;Chen;Cheng-Yi |
| 國立成功大學 |
2022 |
Sorafenib suppresses radioresistance and synergizes radiotherapy-mediated CD8+ T cell activation to eradicate hepatocellular carcinoma
|
Cheng, Cheng C.-C.;Ho, A.-S.;Peng, C.-L.;Chang, J.;Sie, Z.-L.;Wang, C.-L.;Chen, Y.-L.;Chen, Chen C.-Y. |
| 中山醫學大學 |
2019-11 |
Sorafenib treatment on Chinese patients with advanced hepatocellular carcinoma: A study on prognostic factors of the viral and tumor status
|
Lee, Shou-Wu;Lee, Teng-Yu;Peng, Yen-Chun;Yang, Sheng-Shun;Yeh, Hong-Zen;Chang, Chi-Sen |
Showing items 771411-771435 of 2348617 (93945 Page(s) Totally)
<< < 30852 30853 30854 30855 30856 30857 30858 30859 30860 30861 > >>
View [10|25|50] records per page
|
